Scientific advisory group Withdrawal period Type IB variation Rapporteur Reference Member State Variation Scientific advice Transfer of marketing authorisation Product information Sunset clause Third country Product- specific waiver Protocol assistance Somatic cell based medicine Urgent safety restriction Supplementary protection certificate Re- examination Worksharing Risk management plan Type II variation Summary of product characteristics Renewal Specimen Subgroup analysis Specific obligations Trial protocol Safety signal Working party Type IA variation Summary of opinion Reflection paper Serious adverse reaction Regulatory authority Risk minimisation activity Tissue- engineered product Risk management system Referral Route of administration Well- established use Request for supplementary information Scientific advisory group Withdrawal period Type IB variation Rapporteur Reference Member State Variation Scientific advice Transfer of marketing authorisation Product information Sunset clause Third country Product- specific waiver Protocol assistance Somatic cell based medicine Urgent safety restriction Supplementary protection certificate Re- examination Worksharing Risk management plan Type II variation Summary of product characteristics Renewal Specimen Subgroup analysis Specific obligations Trial protocol Safety signal Working party Type IA variation Summary of opinion Reflection paper Serious adverse reaction Regulatory authority Risk minimisation activity Tissue- engineered product Risk management system Referral Route of administration Well- established use Request for supplementary information
(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.
Scientific advisory group
Withdrawal period
Type IB variation
Rapporteur
Reference Member State
Variation
Scientific advice
Transfer of marketing authorisation
Product information
Sunset clause
Third country
Product-specific waiver
Protocol assistance
Somatic cell based medicine
Urgent safety restriction
Supplementary protection certificate
Re-examination
Worksharing
Risk management plan
Type II variation
Summary of product characteristics
Renewal
Specimen
Subgroup analysis
Specific obligations
Trial protocol
Safety signal
Working party
Type IA variation
Summary of opinion
Reflection paper
Serious adverse reaction
Regulatory authority
Risk minimisation activity
Tissue-engineered product
Risk management system
Referral
Route of administration
Well-established use
Request for supplementary information